Kyverna Therapeutics, Inc., a leading biotechnology company focusing on autoimmune diseases, revealed its strategic priorities for the year 2025 and anticipated milestones in a recent press release on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback